LDX — Lumos Diagnostics Holdings Balance Sheet
0.000.00%
Last trade - 00:00- AU$84.05m
- AU$70.34m
- $13.19m
Annual balance sheet for Lumos Diagnostics Holdings, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 7.98 | 3.02 | 6.48 | 1.96 | 15.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.89 | 1.49 | 1.68 | 3.37 | 2.22 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 13.4 | 5.96 | 9.56 | 6.46 | 19.8 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 11 | 8.56 | 7.6 | 6.17 | 7.45 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 36.9 | 25.4 | 26.8 | 20.8 | 40.8 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 12.8 | 8.17 | 12.6 | 8.71 | 13 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 19.1 | 15.9 | 19.7 | 14.7 | 17.9 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 17.9 | 9.5 | 7.11 | 6.16 | 22.9 |
| Total Liabilities & Shareholders' Equity | 36.9 | 25.4 | 26.8 | 20.8 | 40.8 |
| Total Common Shares Outstanding |